Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 23 Sep 2026NICE recommends earlier SGLT2 inhibitor use and comorbidity-led treatment pathwaysTopic: Type 2 diabetes in adults
  • 09 Sep 2026CDC recommends extended 5-day treatment course of artemether/lumefantrineTopic: Malaria
  • 02 Sep 2026Global consensus to rename polycystic ovary syndromeTopic: Polycystic ovary syndrome
  • 14 Aug 2026Uganda confirms Marburg case as Ebola outbreak continuesTopic: Marburg disease
  • 14 Aug 2026European guidance lowers the bar for starting antiviral therapy in chronic HBVTopic: Hepatitis B
  • 30 Jul 2026​NICE recommends teplizumab to delay progression to stage 3 type 1 diabetesTopic: Type 1 diabetes
  • 23 Jul 2026Imaging-based artificial intelligence (AI) models for breast cancer risk assessment added to US guidelinesTopic: Primary invasive breast cancer
  • 22 Jul 2026WHO declares cruise ship outbreak overTopic: Hantavirus cardiopulmonary syndrome
  • 10 Jul 2026First case outside Africa confirmed amidst highest first-month total of any outbreakTopic: Ebola disease
  • 07 Jul 2026US guidance encourages prompt diagnosis and treatment of patients with endometrial cancer.Topic: Endometrial cancer
  • 07 Jul 2026Guidelines recommend long-acting injectable PrEP and a two-drug ART alternative initial regimen as options during pregnancy and breastfeedingTopic: HIV in pregnancy
  • 07 Jul 2026US guidance encourages prompt diagnosis and treatment of patients with endometrial cancer.Topic: Assessment of vaginal bleeding
  • 02 Jul 2026UK National Screening Committee recommends against population screening for prostate cancer, but recommends targeted screeningTopic: Prostate cancer
  • 12 Jun 2026FDA approves first and only oral option for COVID-19 postexposure prophylaxisTopic: Coronavirus disease 2019 (COVID-19)
  • 04 Jun 2026UK NICE guideline update: adjunctive corticosteroids for severe community-acquired pneumonia (NG250)Topic: Community-acquired pneumonia
  • 14 May 2026Tazemetostat withdrawn globally for all indications (including follicular lymphoma) due to risk of secondary haematological malignanciesTopic: Non-Hodgkin's lymphoma
  • 06 May 2026FDA approves new oral antibiotics effective against resistant strains of gonorrhoeaTopic: Urethritis